In human non-small cell lung cancer (NSCLC) cells, Oh et al. (2019) found that LicB inhibited the activities of EGFR and MET kinase and cell viability in HCC827 and HCC827GR cells. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.